SK7502001A3 - 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same - Google Patents

3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same Download PDF

Info

Publication number
SK7502001A3
SK7502001A3 SK750-2001A SK7502001A SK7502001A3 SK 7502001 A3 SK7502001 A3 SK 7502001A3 SK 7502001 A SK7502001 A SK 7502001A SK 7502001 A3 SK7502001 A3 SK 7502001A3
Authority
SK
Slovakia
Prior art keywords
substituted
alkyl
group
cycloalkyl
tert
Prior art date
Application number
SK750-2001A
Other languages
English (en)
Slovak (sk)
Inventor
David L Waterbury
Allan L Wilcox
John M Carney
Farah Mavandadi
Albert Danielzadeh
Original Assignee
Centaur Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centaur Pharmaceuticals Inc filed Critical Centaur Pharmaceuticals Inc
Publication of SK7502001A3 publication Critical patent/SK7502001A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SK750-2001A 1998-12-02 1999-12-01 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same SK7502001A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11054198P 1998-12-02 1998-12-02
PCT/US1999/028479 WO2000032567A1 (en) 1998-12-02 1999-12-01 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same

Publications (1)

Publication Number Publication Date
SK7502001A3 true SK7502001A3 (en) 2002-02-05

Family

ID=22333591

Family Applications (1)

Application Number Title Priority Date Filing Date
SK750-2001A SK7502001A3 (en) 1998-12-02 1999-12-01 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same

Country Status (21)

Country Link
US (1) US6342523B1 (no)
EP (1) EP1135367A1 (no)
JP (1) JP2002531435A (no)
KR (1) KR20010087407A (no)
CN (1) CN1334800A (no)
AU (1) AU773343B2 (no)
BR (1) BR9915886A (no)
CA (1) CA2353402A1 (no)
CZ (1) CZ20011830A3 (no)
EA (1) EA004931B1 (no)
HK (1) HK1044147A1 (no)
HU (1) HUP0104576A3 (no)
IL (1) IL143506A0 (no)
IS (1) IS5958A (no)
NO (1) NO20012727L (no)
NZ (1) NZ512032A (no)
PL (1) PL349916A1 (no)
SK (1) SK7502001A3 (no)
UA (1) UA66401C2 (no)
WO (1) WO2000032567A1 (no)
ZA (1) ZA200104378B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050107366A1 (en) * 1991-06-18 2005-05-19 Carney John M. Spin trapping pharmaceutical compositions and methods for use thereof
US6730700B2 (en) 1998-12-02 2004-05-04 Renovis, Inc. 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
AU2002253857A1 (en) * 2001-01-08 2002-09-04 Centaur Pharmaceuticals, Inc. Use of aryl nitrone compounds in methods for treating neuropathic pain
US20030045461A1 (en) * 2001-09-06 2003-03-06 Jen-Chang Hsia Composition and methods of esterified nitroxides gated with carboxylic acids
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
TW200404069A (en) * 2002-06-28 2004-03-16 Upjohn Co Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
US7115666B2 (en) * 2002-10-15 2006-10-03 Renovis, Inc. Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
US20050059638A1 (en) * 2003-08-04 2005-03-17 Kelly Michael G. Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
US20050182060A1 (en) * 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
WO2005087214A1 (en) * 2004-03-09 2005-09-22 Renovis, Inc. Methods for treating multiple sclerosis and pharmaceutical compositions therefor
US8227517B2 (en) 2008-02-12 2012-07-24 Tosk, Incorporated Doxorubicin adjuvants to reduce toxicity and methods for using the same
CN101468970B (zh) 2008-04-25 2011-05-11 暨南大学 一种硝酮类化合物及其制备方法和在制药中的应用
CN102311396B (zh) * 2010-07-05 2015-01-07 暨南大学 一种吡嗪类衍生物和其制备方法及在制药中的应用
WO2013067084A1 (en) * 2011-11-01 2013-05-10 The Florida International University Board Of Trustees Silylated azulenyl nitrone spin traps as chromotropic superoxide detectors
CN104803880B (zh) * 2014-01-23 2017-11-21 广州喜鹊医药有限公司 一种具有神经保护作用的化合物及其制备方法和应用
CN109438288B (zh) * 2018-10-22 2021-05-07 河南中医药大学 一种n-硝酮取代芳香酰胺衍生物及其制备方法
CA3209491A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224340A (en) 1977-10-06 1980-09-23 William H. Rorer, Inc. Anti-inflammatory compositions containing α-phenyl-N-phenylnitrone compounds
GB2137619A (en) * 1983-03-30 1984-10-10 Gerald Scott Nitrone compounds and stabilised rubber compositions containing them
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
NZ231534A (en) 1988-11-29 1992-02-25 Warner Lambert Co 3,5-di-t-butyl-4-hydroxyphenyl-triazoles, oxadiazoles and thiadiazoles; anti-inflammatory compositions
US5025032A (en) * 1989-10-17 1991-06-18 Oklahoma Medical Research Foundation Phenyl butyl nitrone compositions and methods for treatment of oxidative tissue damage
US5036097A (en) 1989-10-17 1991-07-30 Oklahoma Medical Research Foundation Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration
EP0496796B1 (en) 1989-10-17 1994-08-31 Oklahoma Medical Research Foundation Method and compositions for inhibition of disorders associated with oxidative damage
US5622994A (en) 1989-10-17 1997-04-22 Oklahoma Medical Research Foundation Spin trapping pharmaceutical compositions and methods for use thereof
US5143928A (en) 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
US6002001A (en) 1991-06-18 1999-12-14 Oklahoma Medical Research Foundation Spin trapping pharmaceutical compositions and methods for use thereof
US5270319A (en) 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5215986A (en) 1992-06-01 1993-06-01 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene oxaza heterocycles
US5840746A (en) 1993-06-24 1998-11-24 Merck Frosst Canada, Inc. Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
US5455272A (en) * 1993-10-22 1995-10-03 Oklahoma Medical Research Foundation Spin trap nitronyl hindered phenols
US5488145A (en) 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps
ATE263559T1 (de) 1996-04-23 2004-04-15 Centaur Pharmaceuticals Inc Zubereitungen enhaltend eine nitroneverbindung für die verwendung bei der behandlung von uveitis
EP1021430A1 (en) 1996-07-19 2000-07-26 Centaur Pharmaceuticals, Inc. Furan nitrone compounds
TW429241B (en) * 1996-09-26 2001-04-11 Sumitomo Pharma Nitrone derivatives
US5994396A (en) 1997-08-18 1999-11-30 Centaur Pharmaceuticals, Inc. Furansulfonic acid derivatives and pharmaceutical compositions containing the same
MA26553A1 (fr) 1997-10-17 2004-12-20 Centaur Pharmaceuticals Inc Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
DE69904018D1 (en) 1998-01-16 2003-01-02 Centaur Pharmaceuticals Inc Thiophennitronderivate
ZA99252B (en) 1998-01-16 1999-07-14 Centaur Pharmaceuticals Inc Thioether furan nitrone compounds.
WO1999045909A2 (en) 1998-03-13 1999-09-16 Centaur Pharmaceuticals Use of nitrone compounds for the inhibition of angiogenesis
ATE271384T1 (de) 1998-05-19 2004-08-15 Renovis Inc Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen

Also Published As

Publication number Publication date
KR20010087407A (ko) 2001-09-15
CA2353402A1 (en) 2000-06-08
AU773343B2 (en) 2004-05-20
EP1135367A1 (en) 2001-09-26
CN1334800A (zh) 2002-02-06
EA200100607A1 (ru) 2001-12-24
AU1929800A (en) 2000-06-19
HUP0104576A2 (hu) 2002-05-29
IS5958A (is) 2001-05-31
HUP0104576A3 (en) 2002-11-28
CZ20011830A3 (cs) 2001-10-17
PL349916A1 (en) 2002-10-07
NZ512032A (en) 2004-02-27
EA004931B1 (ru) 2004-10-28
NO20012727D0 (no) 2001-06-01
WO2000032567A1 (en) 2000-06-08
UA66401C2 (en) 2004-05-17
ZA200104378B (en) 2002-08-28
US6342523B1 (en) 2002-01-29
IL143506A0 (en) 2002-04-21
NO20012727L (no) 2001-07-26
HK1044147A1 (zh) 2002-10-11
BR9915886A (pt) 2001-08-21
JP2002531435A (ja) 2002-09-24

Similar Documents

Publication Publication Date Title
SK7502001A3 (en) 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
EP2482815B1 (en) Antiinflammatory 2-oxothiazoles and 2-oxooxazoles
KR102101774B1 (ko) 바독솔론 메틸의 2,2-다이플루오로프로피온아미드 유도체, 그의 다형태 및 사용 방법
US8309766B2 (en) Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof
CA3019890A1 (en) Bioenzymatic synthesis of tetrahydrocannabivarin (thc-v), cannabinol (cbn), and cannabivarin (cbv) and their use as therapeutic agents
AU2008327615A1 (en) Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor
FR2492258A1 (fr) Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
FI71556C (fi) Foerfarande foer framstaellning av 5-(paradeuterofenyl)-5-fenylhydantoin, vilken aer ett laekemedel anvaendbart mot konvulsioner.
US6730700B2 (en) 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
US6835754B2 (en) Use of aryl nitrone compounds in methods for treating neuropathic pain
CA2262223A1 (en) Novel carbocyclic diarylmethylene derivatives, methods for preparing same, and therapeutical uses thereof
AU750599B2 (en) Alpha-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and their use for treating inflammation
NO831950L (no) Farmasoeytiske preparater inneholdende (+)-cyanidan-3-ol-derivater, deres anvendelse, nye substituerte (+)-cyanidan-3-ol-derivater og fremgangsmaater til deres fremstilling
WO2011044479A1 (en) Processes for the preparation of 2-(1-phenylethyl) isoindolin-1-one compounds
MXPA01005555A (en) 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
US20060100289A1 (en) Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
WO2000063160A1 (fr) Derives de 2-alcoxy-cyclobutane-3,4-dione leur preparation et leur application en therapeutique
HU198928B (en) Process for producing tetrahydro-beta-carboline derivatives and pharmaceutical compositions comprising same
FR2593501A1 (fr) Nouveaux derives bis (r-oxyimino)-5,7 dihydro-6,7 (5h) dibenzo (a,c) cycloheptene, leurs procedes de preparation et leur application comme medicaments
EP0026289B1 (en) Antihypertensive polyhalohydroxyisopropyl phenylalkanoic and phenylalkenoic acids, amides and esters, pharmaceutical compositions therefrom and intermediates thereto
FR2593502A1 (fr) Nouveaux derives acyloxy-7 (r-oxyimino)-5 (5h) dibenzo (a,c) cycloheptene, leurs procedes de preparation et leur application comme medicaments